Drug Patent Watch
NOVEMBER 3, 2021
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
NOVEMBER 2, 2021
Open enrollment is under way for the 2022 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. For 2022: 98% of stand-alone Medicare Part D prescription drug plans (PDP) will have a preferred network. 66% of Medicare Advantage prescription drug (MA-PD) plans will have a preferred network.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 5, 2021
Roche and Novartis agree on the repurchase by Roche Holding Ltd of 53.3 million Roche shares from Novartis Holding AG. Repurchase is conditional upon the approval of a capital reduction by cancellation of the repurchased shares and the approval of the interim financial statements prepared for the purpose of the transaction by an Extraordinary General Meeting of Roche Holding Ltd.
Nvidia Developer: Drug Discovery
NOVEMBER 3, 2021
Computational molecular design involves compute-intense calculations that require exceptional processing power. Whether working in pharmaceuticals, Computational molecular design involves compute-intense calculations that require exceptional processing power. Whether working in pharmaceuticals, biotechnology, agrochemicals, or the fragrance industry, researchers are oftentimes dealing with datasets that encompass millions to billions of compounds.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
OCTOBER 30, 2021
This chart shows the pharmaceutical companies with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Norway? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
NOVEMBER 5, 2021
Today’s guest post comes from Ashleigh Burdette, Senior Director of Clinical Innovation at Biologics by McKesson. Ashleigh explains how biopharma companies can help patients become more adherent and achieve better health outcomes by partnering with an experienced specialty pharmacy that offers risk-based care. . To learn more about the risk-based care approach, download the free whitepaper: Risk-Based Care Helps Cancer Treatment Adherence.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Olympian Clinical Research
NOVEMBER 1, 2021
Overcoming social anxiety is a process that takes time and commitment, often beginning in the early ages of childhood and adolescence. Social Anxiety Disorder (SAD) affects 15 million American adults and is prevalent in an estimated 9.1% of adolescents between the ages of 13 and 18. Most children experience an onset of SAD between the ages of eight and 15, and it can be triggered by a traumatic experience or emerge from a natural tendency of shyness. .
Drug Patent Watch
NOVEMBER 4, 2021
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiasma and is included in one NDA. It is available from one supplier. There are seven patents protecting…. The post New patent for Chiasma drug MYCAPSSA appeared first on DrugPatentWatch - Make Better Decisions.
The Strateos Blog: Drug Discovery
NOVEMBER 1, 2021
Between October 11-13th, Strateos was a proud participant at the 20/15 Visioneers Cloud Lab, HTE, Lab Automation Virtual Conference alongside other thought leaders in the space such as PerkinElmer, Dotmatics and Gingko Bioworks. The theme of the conference was how laboratory automation, HTE, and cloud labs are enabling model-quality data generation to drive better, more efficient experimentation to accelerate scientific discoveries.
The Pharma Data
NOVEMBER 5, 2021
– In a new sub-analysis of the landmark EMPEROR-Preserved® phase III trial, Jardiance reduced the combined relative risk of cardiovascular death and hospitalization for heart failure and slowed kidney function decline – Jardiance consistently improved outcomes across the full range of kidney function down to an eGFR of 20 mL/min/1.73 m2.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
NOVEMBER 4, 2021
Annual Drug Patent Expirations for SAVELLA Savella is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There are four patents protecting…. The post New patent expiration for Allergan drug SAVELLA appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 1, 2021
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 1, 2021
Annual Drug Patent Expirations for TECFIDERA Tecfidera is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Biogen Inc drug TECFIDERA appeared first on DrugPatentWatch - Make Better Decisions.
The Pharma Data
NOVEMBER 5, 2021
Producing Medicines for the United States, the Plant Features Innovative Technologies and Advancements in Sustainability. Amgen today announced the groundbreaking of its newest biomanufacturing plant, located in New Albany, Ohio. The final product assembly and packaging plant will support the growing demand for Amgen’s medicines in the United States and is expected to be operational by 2024. “Amgen’s choice to build a cutting-edge facility where approximately 400 Ohioans will a
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Patent Watch
NOVEMBER 5, 2021
This chart shows the drugs with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 5, 2021
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are seventeen…. The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 5, 2021
Abaloparatide is the generic ingredient in one branded drug marketed by Radius Health Inc and is included in one NDA. There are four patents protecting this compound. This ingredient has…. The post New tentative approval for Radius Health drug abaloparatide appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 4, 2021
This chart shows the drugs with the most patents in New Zealand. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical drugs have the most drug patents in New Zealand? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
NOVEMBER 3, 2021
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…. The post New patent expiration for Acorda drug INBRIJA appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 2, 2021
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the greatest global patent coverage? appeared first on DrugPatentWatch - Make Better Decisions.
The Pharma Data
NOVEMBER 1, 2021
Boehringer Ingelheim marks COP26 by announcing updates to its strategic approach to sustainable development The company commits to becoming carbon ne utral in company operations by 2030 and further reducing the overall water footprint, operational waste to landfill and resource use Boehringer Ingelheim implements ambitious internal carbon price of EUR 100 per ton CO2 emissions to foster low carbon technologies and solutions The company invests EUR 130 million to implement strategic green projec
The Pharma Data
NOVEMBER 1, 2021
Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus. Lydia Kavraki, a computer scientist at the George R. Brown School of Engineering, and her colleagues at the University of Houston, the University of Edinburgh, Scotland, and the Federal University of Ceará, Brazil, have posted a “user-friendly” web server offering scientists the chance to screen their drug candid
Drug Patent Watch
NOVEMBER 1, 2021
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are fourteen patents protecting…. The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 1, 2021
Annual Drug Patent Expirations for LEVOTHYROXINE+SODIUM Levothyroxine Sodium is a drug marketed by Teva Pharms Usa Inc, Dr Reddys, Fresenius Kabi Usa, Maia Pharms Inc, Par Sterile Products, Piramal Critical,…. The post New patent for Custopharm Inc drug LEVOTHYROXINE SODIUM appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
OCTOBER 31, 2021
This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Malaysia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
OCTOBER 30, 2021
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…. The post New patent expiration for Alkermes Inc drug LYBALVI appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
NOVEMBER 3, 2021
INBRIJA (levodopa) Acorda Patent: 7,556,798 Expiration: Nov 4, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit…. The post Drug Patent Expirations for the Week of October 31, 2021 appeared first on DrugPatentWatch - Make Better Decisions.
The Pharma Data
NOVEMBER 5, 2021
U.K.’s Medicines and Healthcare Products Regulatory Agency Authorizes Molnupiravir for the Treatment of Mild-to-Moderate COVID-19 in Grown-ups With a Positive SARS-CoV-2 Diagnostic Test and Who Have at Least One Threat Factor for Developing Severe Illness. Operations Remain Under Review by Other Regulatory Authorities, IncludingU.S. Food and Drug Administration and the European Medicines Agency Merck (NYSE MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics mom
The Pharma Data
NOVEMBER 5, 2021
“Sustainable Practices Badge” seeks to encourage the adoption of more sustainable practices by Brazil’s grain growers. Grão Direto, the largest digital platform for grain trading in Latin America, developed in collaboration with Bayer the preface of the “ Sustainable Practices Badge” on its digital business. The emblem indicates which growers on the platform are exercising agronomic practices that are more salutary to the terrain.
Expert insights. Personalized for you.
98 
Let's personalize your content